The present study showed increased IL-10 levels in Ox-AD mice and higher mean IL-10 levels in mice that were topically treated with 11β-HSD1 inhibitor compared to vehicle-treated mice; however, the difference was not statistically significant. This evidence concerns the gene IL10 and Alzheimer disease.